Summit Biosciences Inc. has been acquired by Kindeva Drug Delivery, a global force in drug-device combination product development and manufacturing with expertise across pulmonary & nasal, injectable, and transdermal delivery. Summit brings its innovative nasal spray drug product capabilities to Kindeva, with the capacity to support any stage of product development, from conceptual to commercial, as well as our cGMP facility in Lexington, KY. Under Kindeva’s leadership, our dedicated and talented workforce will continue to drive our vision of increasing the availability of nasal drug-delivery options. For the most up-to-date information and news, please follow Kindeva’s page: https://www.linkedin.com/company/kindeva-drug-delivery/. To explore Kindeva’s leading drug-device CDMO capabilities and proactive, informed solutions, you can also visit www.kindevadd.com.